Cost-Effectiveness Analysis of Transplantation-Ineligible Elderly Patients With Acute Leukemia Harboring a Molecular Target: Ph-Positive Acute Leukemia and FLT3-Mutated Acute Myeloid Leukemia

BACKGROUND: Tyrosine kinase inhibitors (TKIs) and FMS-like tyrosine kinase 3 (FLT3) inhibitors are promising agents for Ph-positive acute leukemia (Ph(+) AL) and FLT3 mutated acute myeloid leukemia (FLT3-AML), respectively. METHODS: We examined the cost-effectiveness ratio (CER) of dasatinib and pon...

Descripción completa

Detalles Bibliográficos
Autores principales: Imataki, Osamu, Ishida, Tomoya, Kida, Jun-ichiro, Uemura, Makiko, Fujita, Haruyuki, Kadowaki, Norimitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635805/
https://www.ncbi.nlm.nih.gov/pubmed/36406948
http://dx.doi.org/10.14740/jocmr4799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635805/
https://www.ncbi.nlm.nih.gov/pubmed/36406948
http://dx.doi.org/10.14740/jocmr4799

Ejemplares similares